0001127602-14-035749.txt : 20141219
0001127602-14-035749.hdr.sgml : 20141219
20141219173530
ACCESSION NUMBER: 0001127602-14-035749
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141218
FILED AS OF DATE: 20141219
DATE AS OF CHANGE: 20141219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAHON PAUL A
CENTRAL INDEX KEY: 0001231589
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 141300802
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-12-18
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001231589
MAHON PAUL A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
EVP & General Counsel
Common Stock
2014-12-18
4
M
0
4750
30.75
A
39582
D
Common Stock
2014-12-18
4
S
0
2289
128.1924
D
37293
D
Common Stock
2014-12-18
4
S
0
2151
128.9779
D
35142
D
Common Stock
2014-12-18
4
S
0
310
130.0132
D
34832
D
Common Stock
2014-12-18
4
M
0
6000
33.14
A
40832
D
Common Stock
2014-12-18
4
S
0
6000
131.11
D
34832
D
Stock Options
30.75
2014-12-18
4
M
0
4750
0
D
2009-09-14
2017-09-14
Common Stock
4750
0
D
Share Tracking Award
33.14
2014-12-18
4
M
0
6000
0
D
2010-03-13
2019-03-13
Common Stock
6000
70750
D
This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
This transaction was executed in multiple trades at prices ranging from $127.73 to $128.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $128.74 to $129.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $129.81 to $130.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
/s/ John S. Hess, Jr. under Power of Attorney
2014-12-19